ARCHIVES

FDA Committee Approves NDA for Mitxantrone

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

April 4, 1986

HHS Appoints 13 To Genetics Committee

January 17, 2003

Health Policy: Organ Procurement Should Cover Wider Areas, IOM Report Says

August 6, 1999

DCCR Plans Three Multiple Contracts In Pain Control

February 17, 1978

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

August 3, 1990

Tumor Size Predicts Survival In Early-Stage Lung Cancer

November 28, 2003